Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New Dietary Ingredient Notification Draft Guidance Must Be Withdrawn – CRN and CHPA

05 Dec 2011

• By Carolyn B. Phenicie

Related Content

NDI Guidance Protects Public Health And Allows Innovation – FDA's Fabricant

11 Jul 2011

FDA “Undercuts” NDI Guidance Opposition With Compliance Cost Estimate – CRN

21 Nov 2011

Additional Topics

United States Regulation OTC Drugs Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.